Verve Therapeutics (VERV) Stock Chart & Stock Price History $11.22 +0.02 (+0.13%) Closing price 03:11 PM EasternExtended Trading$11.22 0.00 (0.00%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Verve Therapeutics Stock Price Performance The Verve Therapeutics (VERV) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 118.39%, with a year-to-date return of 99.02%. In the past month, the stock has increased 131.92%, reflecting recent market activity. As of the latest close, Verve Therapeutics traded at $11.21 with a market cap of $999.26 million and volume of 3.18 million shares. Receive VERV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Verve Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.66%1 Month Performance+131.92%3 Month Performance+191.56%Year-To-Date Performance+99.02%1 Year Performance+118.39% VERV Stock Chart for Thursday, July, 3, 2025 VERV Chart by TradingView Verve Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/02/2025$11.28$11.21-0.62%$11.34$11.213.18 million shs$999.26 million07/01/2025$11.23$11.28+0.45%$11.33$11.164.13 million shs$1.01 billion06/30/2025$11.30$11.23-0.62%$11.33$11.173.22 million shs$1.00 billion06/27/2025$11.26$11.30+0.36%$11.32$11.234.14 million shs$1.01 billion06/26/2025$11.21$11.26+0.45%$11.27$11.174.11 million shs$1.00 billion06/25/2025$11.17$11.21+0.36%$11.21$11.133.34 million shs$999.29 million06/24/2025$11.11$11.17+0.54%$11.19$11.092.99 million shs$995.69 million06/23/2025$11.06$11.11+0.45%$11.19$11.045.51 million shs$990.35 million06/20/2025$11.12$11.06-0.54%$11.17$11.057.72 million shs$985.92 million06/19/2025$11.12$11.12$11.26$11.1013.05 million shs$991.24 million Get the Latest News and Ratings for VERV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Verve Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/18/2025$11.38$11.12-2.28%$11.26$11.1013.05 million shs$991.24 million06/17/2025$6.27$11.38+81.50%$11.41$10.8583.35 million shs$1.01 billion06/16/2025$6.16$6.27+1.79%$6.41$5.942.21 million shs$558.93 million06/13/2025$6.32$6.16-2.53%$6.26$5.881.71 million shs$549.12 million06/12/2025$6.39$6.32-1.10%$6.39$6.101.28 million shs$563.38 million06/11/2025$6.39$6.39$6.67$6.362.03 million shs$569.62 million06/10/2025$6.10$6.39+4.75%$6.54$6.012.60 million shs$569.62 million06/09/2025$6.20$6.10-1.61%$6.48$5.783.60 million shs$543.77 million06/06/2025$5.73$6.20+8.20%$6.58$5.774.67 million shs$552.69 million06/05/2025$5.29$5.73+8.32%$6.18$5.186.96 million shs$510.79 million06/04/2025$4.84$5.29+9.30%$5.43$4.853.47 million shs$471.57 million06/03/2025$4.80$4.84+0.83%$5.01$4.622.28 million shs$431.45 million06/02/2025$4.43$4.80+8.35%$5.10$4.503.50 million shs$427.89 million Related Companies Rhythm Pharmaceuticals Stock Chart PTC Therapeutics Stock Chart Cytokinetics Stock Chart ACADIA Pharmaceuticals Stock Chart Merus Stock Chart SpringWorks Therapeutics Stock Chart Avidity Biosciences Stock Chart Arcellx Stock Chart Ultragenyx Pharmaceutical Stock Chart Protagonist Therapeutics Stock Chart Receive VERV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Verve Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VERV) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verve Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Verve Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
